+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Interleukin"

Interleukin (IL)-4 Antibody Market Report 2026 - Product Thumbnail Image

Interleukin (IL)-4 Antibody Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
InterLeukin6 IL6 Inhibitor Market Report 2026 - Product Thumbnail Image

InterLeukin6 IL6 Inhibitor Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Crohn's Disease Therapeutics Market - Global Forecast 2026-2032 - Product Thumbnail Image

Crohn's Disease Therapeutics Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 183 Pages
  • Global
From
Anti-Rheumatics Market - Global Forecast 2026-2032 - Product Thumbnail Image

Anti-Rheumatics Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 194 Pages
  • Global
From
Collagen Vascular Diseases Market - Global Forecast 2026-2032 - Product Thumbnail Image

Collagen Vascular Diseases Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 191 Pages
  • Global
From
From
From
Psoriasis Drugs Market - Global Forecast 2026-2032 - Product Thumbnail Image

Psoriasis Drugs Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 199 Pages
  • Global
From
Autoimmune Disease Therapeutics Market - Global Forecast 2026-2032 - Product Thumbnail Image

Autoimmune Disease Therapeutics Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 181 Pages
  • Global
From
Gout Therapeutics Market - Global Forecast 2026-2032 - Product Thumbnail Image

Gout Therapeutics Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 193 Pages
  • Global
From
Atopic Dermatitis Drugs Market - Global Forecast 2026-2032 - Product Thumbnail Image

Atopic Dermatitis Drugs Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 192 Pages
  • Global
From
Periodic Fever Syndrome - Global Strategic Business Report - Product Thumbnail Image

Periodic Fever Syndrome - Global Strategic Business Report

  • Report
  • September 2026
  • 390 Pages
  • Global
From
From
Psoriatic Arthritis Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Psoriatic Arthritis Therapeutics - Global Strategic Business Report

  • Report
  • September 2026
  • 276 Pages
  • Global
From
Interleukin Inhibitors - Global Strategic Business Report - Product Thumbnail Image

Interleukin Inhibitors - Global Strategic Business Report

  • Report
  • September 2026
  • 288 Pages
  • Global
From
Atopic Dermatitis Drugs - Global Strategic Business Report - Product Thumbnail Image

Atopic Dermatitis Drugs - Global Strategic Business Report

  • Report
  • September 2026
  • 351 Pages
  • Global
From
Ulcerative Colitis Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Ulcerative Colitis Therapeutics - Global Strategic Business Report

  • Report
  • September 2026
  • 208 Pages
  • Global
From
Immunosuppressants - Global Strategic Business Report - Product Thumbnail Image

Immunosuppressants - Global Strategic Business Report

  • Report
  • September 2026
  • 349 Pages
  • Global
From
Loading Indicator

Interleukins are a group of cytokines, or proteins, that are involved in the regulation of the immune system. They are produced by a variety of cells, including T cells, B cells, and macrophages, and are involved in a wide range of biological processes, including inflammation, cell growth, and differentiation. Genomics has enabled researchers to better understand the role of interleukins in the immune system, and to develop new therapies for a variety of diseases. In recent years, the interleukin market has grown significantly, with a number of companies developing new therapies and diagnostic tests. Companies such as AbbVie, Amgen, and Novartis are developing new interleukin-based therapies for a variety of diseases, while companies such as Genentech and Merck are developing diagnostic tests to detect interleukin levels in patients. Additionally, a number of biotechnology companies are developing new interleukin-based therapies for a variety of diseases. Show Less Read more